AlivaMab Biologics

AlivaMab Biologics provides fully integrated solutions for biologics drug discovery through our expanding platform of innovative capability modules. AMBs customizable capability modules include target validation, protein- and cell-based tool engineering and production, sophisticated functional assay development and execution, discovery of binding domains using Ablexis family of AlivaMab Mouse strains, kinetic and epitope characterization, protein and antibody engineering across a breadth of novel biologic drug modalities, full-depth developability assessment, antibody optimization, and production up to medium scale. AMBs partners also gain from the teams direct experience and know-how in the discovery and development of biologics drugs across various modalities. Partners may...

Antibody discovery,antibody therapies,antibody therapeutics,monoclonal antibody discovery,antibody engineering,bispecific antibodies,antibody drug conjugates,functional antibody leads,transgenic mouse,antibody discovery services,hybridoma,dna immunization,protein immunization,cellular immunization,protein expression and purification,and developability assessment

Alivamab biologics operates in the Biotechnology research industry.

Alivamab biologics's revenue is 11m - 100m

Alivamab biologics has 11 - 50 employees.